Mild moxibustion for Irritable Bowel Syndrome with Diarrhea (IBS-D): A randomized controlled trial

肠易激综合征 医学 艾灸 腹泻 针灸科 随机对照试验 安慰剂 腹痛 内科学 中医药 传统医学 胃肠病学 替代医学 病理
作者
Zhaoqin Wang,Manwen Xu,Zheng Shi,Chunhui Bao,Huirong Liu,Cili Zhou,Yilu Yan,Chunye Wang,Guona Li,Wei Zhang,Anqi Gao,Huangan Wu
出处
期刊:Journal of Ethnopharmacology [Elsevier BV]
卷期号:289: 115064-115064 被引量:28
标识
DOI:10.1016/j.jep.2022.115064
摘要

Moxibustion therapy is a traditional Chinese medicine external treatment method, which involves crushing dried herb Artemisia argyi H. Lév. & Vanio and rolling it into a long cigarette-like strip, igniting it and using its warmth to stimulate specific acupuncture points for a certain period of time. It is often used in Asia to treat various diseases, especially abdominal pain. Clinical reports suggest that acupuncture and moxibustion are the effective treatment for Irritable Bowel Syndrome with Diarrhea (IBS-D). However, there is no placebo-controlled study to prove its safety and efficacy.To evaluate the effects of mild moxibustion (MM) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) through comparisons with those of placebo moxibustion.This was a single-site, randomized controlled trial was conducted at Shanghai Research Institute of Acupuncture and Meridian in China and enrolled 76 participants who met the Rome IV diagnostic criteria for IBS-D between May 2017 and December 2019. 76 participants were randomized to either mild moxibustion (MM) or placebo moxibustion group (PM) in a 1:1 ratio. 18 sessions of MM or PM were implemented over the course of 6 weeks (3 times per week). The primary outcome was adequate relief after 6 weeks of treatment.Of 76 patients with IBS-D who were randomized (38 in the MM group and 38 in the PM group) were included in the intention-to-treat (ITT) analysis set. After treatment at week 6, the response rate was significantly higher in the MM group than the PM group (81.58% vs. 36.84%) with an estimated difference of 44.74 (95% CI, 23.46 to 66.02, P < 0.001). No participant reported severe adverse effects.The findings suggest that mild moxibustion may be more effective than placebo moxibustion for the treatment of IBS-D, with effects lasting up to 12 weeks.ChiCTR, ChiCTR2100046852. Registered 29 May 2021 - Retrospectively registered, URL: http://www.chictr.org.cn/showproj.aspx?proj=127000.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
理工完成签到,获得积分20
刚刚
2秒前
ytolll发布了新的文献求助10
2秒前
4秒前
愉快道之完成签到,获得积分10
4秒前
_glimmer完成签到,获得积分10
4秒前
共享精神应助wzc采纳,获得10
5秒前
rosy完成签到,获得积分10
5秒前
曾泳钧完成签到,获得积分10
5秒前
宁静致远发布了新的文献求助10
5秒前
biov完成签到,获得积分10
5秒前
斯文的酒窝完成签到 ,获得积分10
5秒前
Barry完成签到,获得积分10
5秒前
wszbg完成签到,获得积分20
6秒前
心灵美千秋完成签到 ,获得积分10
6秒前
丰知然应助黑色天空采纳,获得10
6秒前
易寒完成签到,获得积分10
6秒前
8秒前
firefly完成签到 ,获得积分10
8秒前
香草应助PipiXian采纳,获得10
9秒前
曹中明完成签到,获得积分10
9秒前
10秒前
10秒前
ganchao1776完成签到,获得积分10
10秒前
orixero应助ytolll采纳,获得10
11秒前
阳光念桃完成签到,获得积分10
11秒前
鑫xx完成签到 ,获得积分10
11秒前
11秒前
Christian完成签到,获得积分10
11秒前
乐乐应助科研通管家采纳,获得80
11秒前
iNk应助科研通管家采纳,获得10
12秒前
科目三应助科研通管家采纳,获得10
12秒前
1199应助科研通管家采纳,获得10
12秒前
啦啦完成签到 ,获得积分10
12秒前
风信子完成签到,获得积分10
12秒前
wjj123应助科研通管家采纳,获得30
12秒前
FelixChen应助科研通管家采纳,获得10
12秒前
iNk应助科研通管家采纳,获得10
12秒前
FelixChen应助科研通管家采纳,获得10
12秒前
12秒前
高分求助中
Africanfuturism: African Imaginings of Other Times, Spaces, and Worlds 3000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 2000
The Oxford Encyclopedia of the History of Modern Psychology 2000
Synthesis of 21-Thioalkanoic Acids of Corticosteroids 1000
Electron microscopy study of magnesium hydride (MgH2) for Hydrogen Storage 1000
Structural Equation Modeling of Multiple Rater Data 700
 Introduction to Comparative Public Administration Administrative Systems and Reforms in Europe, Third Edition 3rd edition 590
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3886144
求助须知:如何正确求助?哪些是违规求助? 3428265
关于积分的说明 10759171
捐赠科研通 3153061
什么是DOI,文献DOI怎么找? 1740829
邀请新用户注册赠送积分活动 840369
科研通“疑难数据库(出版商)”最低求助积分说明 785348